苯二氮䓬难治性癫痫持续状态:叙述性综述
本文为叙述性综述,聚焦急诊科苯二氮䓬难治性癫痫持续状态的病因与管理。癫痫持续状态可占急诊癫痫病例的22%,其中高达40%对苯二氮䓬治疗难治。潜在病因包括内分泌、代谢、感染、神经、产科、中毒和创伤性病因,逆转这些病因有助于终止发作。苯二氮䓬(劳拉西泮、地西泮、咪达唑仑)为一线抗癫痫药物,须给予足够剂量以达到最大疗效;持续发作者应在5分钟时接受第二剂苯二氮䓬并联合二线抗癫痫药物(磷苯妥英优于苯妥英、左乙拉西坦或丙戊酸)。仍持续发作者视为难治性癫痫持续状态,应接受三线药物(氯胺酮、戊巴比妥、丙泊酚或硫喷妥)并准备插管;从二线转三线或需插管时应考虑持续脑电图监测。早期积极治疗是终止发作的关键。
要点
- 癫痫持续状态可占急诊癫痫病例的22%,其中高达40%对苯二氮䓬治疗难治。
- 苯二氮䓬(劳拉西泮、地西泮、咪达唑仑)为一线抗癫痫药物,须给予足够剂量以达到最大治疗潜力。
- 持续发作者应在5分钟时接受第二剂苯二氮䓬,并联合二线抗癫痫药物如磷苯妥英(优于苯妥英)、左乙拉西坦或丙戊酸。
- 仍持续发作者视为难治性癫痫持续状态,应接受三线药物如氯胺酮、戊巴比妥、丙泊酚或硫喷妥,同时准备插管。
- 从二线转三线抗癫痫药物或需插管时,应考虑持续脑电图监测;早期积极治疗是终止发作的关键。
适用人群与场景
- 急诊科就诊的癫痫发作患者,尤其是苯二氮䓬难治性癫痫持续状态患者。
诊断标准与关键阈值
- 持续发作者应在5分钟时接受第二剂苯二氮䓬,并联合二线抗癫痫药物。
- 仍持续发作者视为难治性癫痫持续状态,应接受三线药物。
处置流程与药物剂量
- 一线:苯二氮䓬(劳拉西泮、地西泮、咪达唑仑)作为一线抗癫痫药物,须给予足够剂量以达到最大治疗潜力。
- 第二步:持续发作者在5分钟时接受第二剂苯二氮䓬,联合二线抗癫痫药物如磷苯妥英(优于苯妥英)、左乙拉西坦或丙戊酸。
- 第三步:仍持续发作者视为难治性癫痫持续状态,接受三线药物如氯胺酮、戊巴比妥、丙泊酚或硫喷妥,同时准备插管。
- 从二线转三线抗癫痫药物或需插管时,应考虑持续脑电图监测。
- 逆转潜在病因(内分泌、代谢、感染、神经、产科、中毒和创伤性病因)有助于终止癫痫发作。
红旗征与不能漏的情况
- 持续发作者在5分钟时仍未终止,需追加第二剂苯二氮䓬并联合二线抗癫痫药物。
- 仍持续发作者视为难治性癫痫持续状态,需三线药物并准备插管。
研究设计与关键结果
- 叙述性综述:癫痫持续状态可占急诊癫痫病例的22%,其中高达40%对苯二氮䓬治疗难治。
- 长时间癫痫发作与长期神经学后果相关;潜在病因包括内分泌、代谢、感染、神经、产科、中毒和创伤性病因。
证据类型、等级与局限
- 证据类型:叙述性综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 苯二氮䓬作为一线抗癫痫药物须给予足够剂量以达到最大治疗潜力。
- 持续发作者应在5分钟时接受第二剂苯二氮䓬并联合二线抗癫痫药物,而非仅重复苯二氮䓬。
- 二线药物中磷苯妥英优于苯妥英;仍持续发作者应使用三线药物并准备插管。
- 从二线转三线或需插管时应考虑持续脑电图监测。
- 早期积极治疗是终止癫痫发作的关键,应同时识别并逆转潜在病因。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Seizures are a common complaint in the emergency department, with status epilepticus (SE) associated with significant morbidity and mortality. While the typical first-line therapy for seizures includes benzodiazepines, patients with SE may be refractory to benzodiazepines. Seizures of longer duration are harder to break, and SE becomes a self-sustaining cycle; thus, benzodiazepine-refractory SE is a particularly challenging condition facing emergency clinicians.
OBJECTIVES: This narrative review provides a focused evaluation of SE refractory to first-line therapy, highlighting potential underlying causes and management strategies.
DISCUSSION: SE may occur in 22 % of seizure cases presenting to the emergency department, and up to 40 % of these patients will have seizure activity refractory to benzodiazepine therapy. Prolonged seizure activity is associated with long-term neurologic consequences. Potential underlying causes of SE include endocrine, metabolic, infectious, neurologic, obstetric, toxicologic, and traumatic etiologies. Reversing these underlying causes can help terminate seizure activity. Benzodiazepines (lorazepam, diazepam, and midazolam) are considered first-line anti-seizure medications (ASMs) and must be administered in adequate doses to reach their maximum therapeutic potential. Patients who continue seizing should receive a second dose of benzodiazepines at the 5-min mark, combined with a second-line ASM, such as fosphenytoin (preferred over phenytoin), levetiracetam, or valproic acid. Patients who continue seizing are considered to have refractory SE and should receive third-line agents, such as ketamine, pentobarbital, propofol, or thiopental, as the clinician prepares for intubation. Continuous electroencephalography (EEG) should be considered when moving from second- to third-line ASMs or when intubation is necessary. Early aggressive therapy is key for terminating seizure activity.
CONCLUSION: Recognizing and treating SE early is critical for preserving neurologic function. Emergency clinicians must be prepared to reverse the underlying causes of SE and utilize second- and third-line ASMs to abort seizure activity when necessary.
参考来源
- Pelletier J, Merriman W, Koyfman A, et al. Benzodiazepine-refractory status epilepticus: A narrative review. Am J Emerg Med. 2025. PMID: 40974752. doi:10.1016/j.ajem.2025.09.019
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。